Snowball logo
logo
6005_logo

Tasly Pharmaceutical Group Co Ltd

600535 SHG
¥15.43+¥0.12  (0.78%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
7,9528,637.48,6748,498.18,236.58,346.4
COGS
2,682.53,147.42,885.22,809.72,7302,667.6
Gross Profit
5,269.55,4905,788.85,688.45,506.55,678.8
Operating Expenses & Income
Operating Income
2,732.9(160.1)1,227.91,075.91,350.41,400.4
Total Operating Expenses
2,536.55,650.14,560.94,612.54,151.54,902.1
R&D Expenses
579.5845.3917.3830.1685.71,095.4
Selling General & Admin Expenses
432.1374342.4345.4334.21,271.1
Earnings from Continuing Operations
Interest Expense
(80.96)(69.9)(87.26)(64.8)(34.02)(23.37)
Interest Income
34.2740.63107.591.0558.3441.25
Income Tax Expense
315.9180.8204.5209.6283.9208
Net Income
Net Income
2,358.9(264.2)1,071.1955.61,105.41,161.3
Supplemental
EBIT
2,804.5(97.74)1,308.41,133.51,340.7-
EBITDA
3,209.6336.21,813.31,529.81,737-
In millions of CNY, except % and values per 1 share